[Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs].
Lazebnik
L B
LB
Mikheeva
O M
OM
Drozdov
V N
VN
Petrakov
A V
AV
Sil'vestrova
S Iu
SIu
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D001262:Atenolol / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D018660:Blood Pressure Monitoring, Ambulatory; D001919:Bradycardia / Q000139:chemically induced; D004066:Digestive System Diseases / Q000150:complications* / Q000378:metabolism; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate; D008790:Metoprolol / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D008875:Middle Aged
D000959:Antihypertensive Agents; D001262:Atenolol; D008790:Metoprolol